Understanding Options for ESR1-Mutated Breast Cancer
Comprehending ESR1 mutations in breast cancer reveals significant challenges and advancements in treatment. These mutations contribute to resistance against hormonal therapies in metastatic cases. Detection techniques like liquid biopsies and therapeutic strategies are evolving, including trials and personalized approaches. Understanding this dynamic landscape is crucial for optimizing patient care in endocrine-resistant breast cancer. Understanding ESR1-Mutated […]
3 minute read